Literature DB >> 23549658

Green-light fundus autofluorescence in diabetic macular edema.

Lukas Reznicek1, Simeon Dabov, Christos Haritoglou, Anselm Kampik, Marcus Kernt, Aljoscha S Neubauer.   

Abstract

AIM: To evaluate the role of central green-light fundus autofluorescence (FAF) in diabetic macular edema (DME).
METHODS: A consecutive series of 92 study eyes with diabetic retinopathy were included. Out of those, 51 diabetic eyes had DME and were compared to 41 diabetic eyes without DME. In all subjects, green-light FAF images were obtained, quantified and classified into various FAF patterns. Cross-sectional optical coherence tomography (OCT) scans were obtained for evaluation of Inner/Outer segment (IS/OS) layer integrity, measurements of central RPE-IS/OS layer thickness as well as classification of DME into various subtypes.
RESULTS: Mean central green-light FAF intensity of eyes with DME (1.289±0.140)log did not significantly differ from diabetic patients without DME (1.317±0.137)log. Most classifiable FAF patterns were seen in patients with cystoid DME. Mean central retinal thickness (CRT) of all study eyes with DME was (501.9±112.4)µm compared to (328.2±27.0)µm in diabetic patients without DME. Patients with DME had significantly more disrupted photoreceptor IS/OS layers than diabetic patients without DME (28/51 vs 5/41, P<0.001). Mean RPE-IS/OS thickness of patients with DME (60.7±14.1)µm was significantly (P<0.001) lower than in diabetic eyes without DME (73.5±9.4)µm. Correlation analys1s revealed non-significant correlations of green-light FAF intensity and OCT parameters in all subtypes of DME.
CONCLUSION: Our results indicate a poor correlation of central green-light FAF intensity with CRT, IS/OS layer integrity or RPE-IS/OS layer thickness in diabetic patients with or without DME and its various subtypes. Thus, central green-light FAF is not suitable for detection of retinal thickening in DME.

Entities:  

Keywords:  diabetic macular edema; fundus autofluorescence; optical coherence tomography

Year:  2013        PMID: 23549658      PMCID: PMC3580255          DOI: 10.3980/j.issn.2222-3959.2013.01.16

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  44 in total

Review 1.  Advanced glycation: an important pathological event in diabetic and age related ocular disease.

Authors:  A W Stitt
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

2.  Diabetic macular edema.

Authors:  Mark Gillies
Journal:  Ophthalmology       Date:  2009-03       Impact factor: 12.079

3.  Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion.

Authors:  M Morigi; S Angioletti; B Imberti; R Donadelli; G Micheletti; M Figliuzzi; A Remuzzi; C Zoja; G Remuzzi
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

4.  Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. Early Treatment Diabetic Retinopathy Study Research Group.

Authors: 
Journal:  Ophthalmology       Date:  1987-07       Impact factor: 12.079

5.  Fundus autofluorescence and spectral domain optical coherence tomography in uveitic macular edema.

Authors:  Martin Roesel; Andreas Henschel; Carsten Heinz; Martha Dietzel; Georg Spital; Arnd Heiligenhaus
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-08-11       Impact factor: 3.117

6.  The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.

Authors:  Paul Mitchell; Francesco Bandello; Ursula Schmidt-Erfurth; Gabriele E Lang; Pascale Massin; Reinier O Schlingemann; Florian Sutter; Christian Simader; Gabriela Burian; Ortrud Gerstner; Andreas Weichselberger
Journal:  Ophthalmology       Date:  2011-04       Impact factor: 12.079

Review 7.  Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress.

Authors:  Ruth B Caldwell; Manuela Bartoli; M Ali Behzadian; Azza E B El-Remessy; Mohamed Al-Shabrawey; Daniel H Platt; Gregory I Liou; R William Caldwell
Journal:  Curr Drug Targets       Date:  2005-06       Impact factor: 3.465

8.  Effects of macular ischemia on the outcome of intravitreal bevacizumab therapy for diabetic macular edema.

Authors:  Eun Jee Chung; Mi In Roh; Oh Woong Kwon; Hyoung Jun Koh
Journal:  Retina       Date:  2008 Jul-Aug       Impact factor: 4.256

9.  Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.

Authors:  Daniel Kook; Atmin Wolf; Thomas Kreutzer; Aljoscha Neubauer; Rupert Strauss; Michael Ulbig; Anslem Kampik; Christos Haritoglou
Journal:  Retina       Date:  2008-10       Impact factor: 4.256

Review 10.  Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review.

Authors:  Taygan Yilmaz; Christopher D Weaver; Micheal J Gallagher; Miguel Cordero-Coma; Rene A Cervantes-Castaneda; Dino Klisovic; Alejandro J Lavaque; Robin J Larson
Journal:  Ophthalmology       Date:  2009-05       Impact factor: 12.079

View more
  8 in total

1.  Clinical relevance of quantified fundus autofluorescence in diabetic macular oedema.

Authors:  S Yoshitake; T Murakami; A Uji; N Unoki; Y Dodo; T Horii; N Yoshimura
Journal:  Eye (Lond)       Date:  2015-03-13       Impact factor: 3.775

2.  Scanning laser 'en face' retinal imaging of epiretinal membranes.

Authors:  Lukas Reznicek; Simeon Dabov; Bader Kayat; Raffael Liegl; Anselm Kampik; Michael Ulbig; Marcus Kernt
Journal:  Saudi J Ophthalmol       Date:  2014-03-24

Review 3.  Fundus Autofluorescence and Clinical Applications.

Authors:  Cameron Pole; Hossein Ameri
Journal:  J Ophthalmic Vis Res       Date:  2021-07-29

4.  Granular lesions of short-wavelength and near-infrared autofluorescence in diabetic macular oedema.

Authors:  Shin Yoshitake; Tomoaki Murakami; Akihito Uji; Masahiro Fujimoto; Yoko Dodo; Kiyoshi Suzuma; Akitaka Tsujikawa
Journal:  Eye (Lond)       Date:  2018-10-31       Impact factor: 3.775

5.  Monotherapy laser photocoagulation for diabetic macular oedema.

Authors:  Eliane C Jorge; Edson N Jorge; Mayra Botelho; Joyce G Farat; Gianni Virgili; Regina El Dib
Journal:  Cochrane Database Syst Rev       Date:  2018-10-15

6.  Assessment of β-zone peripapillary atrophy by optical coherence tomography and scanning laser ophthalmoscopy imaging in glaucoma patients.

Authors:  Florian Seidensticker; Lukas Reznicek; Thomas Mann; Irene Hübert; Anselm Kampik; Michael Ulbig; Christoph Hirneiss; Aljoscha S Neubauer; Marcus Kernt
Journal:  Clin Ophthalmol       Date:  2014-06-27

7.  Correlation between peripapillary retinal nerve fiber layer thickness and fundus autofluorescence in primary open-angle glaucoma.

Authors:  Lukas Reznicek; Florian Seidensticker; Thomas Mann; Irene Hübert; Alexandra Buerger; Christos Haritoglou; Aljoscha S Neubauer; Anselm Kampik; Christoph Hirneiss; Marcus Kernt
Journal:  Clin Ophthalmol       Date:  2013-09-19

8.  Autofluorescence indexes as biomarkers for antiangiogenic loading dose outcome in diabetic macular edema.

Authors:  Sergio E Hernández Da Mota; Francisco Béjar Cornejo; Marcela Esquivel Velázquez; Virgilio Lima Gómez; Gerardo González Saldívar; Ernesto Rodríguez Ayala; Raul Vélez-Montoya
Journal:  Ther Adv Ophthalmol       Date:  2020-08-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.